Ponoi Capital, Lp - Net Worth and Insider Trading

Ponoi Capital, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ponoi Capital, Lp owns 7 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .

Click here to see the complete history of Ponoi Capital, Lp’s form 4 insider trades.

Insider Ownership Summary of Ponoi Capital, Lp

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2021-08-18	10 percent owner
NGM	NGM Biopharmaceuticals Inc	2019-08-07	10 percent owner
NRIX	Nurix Therapeutics Inc	2021-05-07	10 percent owner
		2020-11-16	10 percent owner
		2020-03-19	10 percent owner
		2019-04-02	10 percent owner
		2018-03-14	10 percent owner

Ponoi Capital, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ponoi Capital, Lp Ownership Network

Ownership Network List of Ponoi Capital, Lp

No Data

Ownership Network Relation of Ponoi Capital, Lp

Ponoi Capital, Lp Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Ponoi Capital, Lp is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Ponoi Capital, Lp made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Ponoi Capital, Lp is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include 10 percent owner Column Group L P , director & 10 percent owner David V Goeddel , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Ponoi Capital, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Ponoi Capital, Lp is the 10 percent owner of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Ponoi Capital, Lp made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nurix Therapeutics Inc Insider Transactions

No Available Data

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Ponoi Capital, Lp is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Ponoi Capital, Lp made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Ponoi Capital, Lp is the 10 percent owner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

Ponoi Capital, Lp is the 10 percent owner of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Ponoi Capital, Lp is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include Chief Accounting Officer Alexander Azoy , See Remarks Jennifer Jarrett , and director & 10 percent owner & President Juan C. Jaen .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Ponoi Capital, Lp made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 196,515 shares made by Jennifer Jarrett , a net purchase of 16,248,095 shares made by Gilead Sciences Inc , and a net sale of 34,007 shares made by Juan C. Jaen .

In summary, during the past 3 months, insiders sold 0 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,214 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 16,009,881 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcus Biosciences Inc Insider Transactions

No Available Data

Ponoi Capital, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Ponoi Capital, Lp. You might contact Ponoi Capital, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.